Water → 2,4-Bis(methyloxy)-5-(2-methyl-1,3-thiazol-4-yl)pyrimidine

HRID 1925022Notes

Reaction equation

HRID 1925022 reaction equation
Br[C:2]1[N:3]=[C:4]([CH3:7])[S:5][CH:6]=1.[CH3:8][O:9][C:10]1[N:15]=[C:14]([O:16][CH3:17])[C:13](B(O)O)=[CH:12][N:11]=1.O.C([O-])(O)=O.[Na+]>COCCOC.ClCCl>[CH3:8][O:9][C:10]1[N:15]=[C:14]([O:16][CH3:17])[C:13]([C:2]2[N:3]=[C:4]([CH3:7])[S:5][CH:6]=2)=[CH:12][N:11]=1

Participants

7

Conditions

Temperature
90 °C

Procedure

4-bromo-2-methyl-1,3-thiazole (commercially available from Frontier, 300 mg, 1.685 mmol) was dissolved in 1,2-Dimethoxyethane (DME) (5 ml). Pd(Ph3)4 (97 mg, 0.084 mmol) was added and the reaction mixture was stirred at room temperature for 15 min. [2,4-bis(methyloxy)-5-pyrimidinyl]boronic acid (commercially available from Aldrich, 651 mg, 3.54 mmol) and 1M/H2O sol. of NaHCO3 (4.60 ml, 4.60 mmol) were added thereto. The reaction mixture was heated at 90° C. for 2.5 h and left at room temperature overnight. The mixture was then diluted with dichloromethane (20 ml) and washed with water (20 ml). The organic layer was separated through an hydrophobic frit and concentrated. The obtained crude was purified by flash chromatography eluting with Cyclohexane/AcOEt 8/2. 290 mg of the title compound were isolated as a white solid.

Workup

  1. additionwere added
  2. washwashed with water (20 ml)
  3. customThe organic layer was separated through an hydrophobic frit
  4. concentrationconcentrated
  5. customThe obtained crude
  6. customwas purified by flash chromatography
  7. washeluting with Cyclohexane/AcOEt 8/2

Sources & evidence

ORD record
ord-ccc0413084de4899a032057559aca432
Source dataset
uspto-grants-2012_05
Patent number
US08178549B2

Reaction notes

Loading…